Lakefront Biotherapeutics NV
Summary
Lakefront Biotherapeutics NV is registered in Belgium and entered in the “Crossroads Bank for Enterprises (KBO/BCE)” under number 0466.460.429. Its legal form is Naamloze vennootschap (NV) – public limited company (Belgium). Lakefront Biotherapeutics NV is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 26 Feb 2015 and the record was last updated on 5 Aug 2026; the next renewal is due by 5 Aug 2027. GLEIF's ISIN mapping lists 1 ISIN for this LEI.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Naamloze vennootschap (NV) public limited company (Belgium) |
|---|---|
| Register | Crossroads Bank for Enterprises (KBO/BCE) · Register website |
| Registration number | 0466.460.429 |
| Registration authority | Federal Public Service Economy (Ministry of Economy) |
| Jurisdiction | Belgium |
| Registered address | Schaliënhoevedreef 20T, 2800 Mechelen, Belgium |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 5 Jun 1999 |
| LEI | 549300QKJ78IY0IOV655 |
| LEI status | active |
| LEI first issued | 26 Feb 2015 |
| LEI record last updated | 5 Aug 2026 |
| Next LEI renewal | 5 Aug 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
- Ultimate parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
Direct subsidiaries (1)
- Galapagos Cell Therapeutics Belgium · Mechelen
ISINs mapped to this LEI (1)
BE0003818359
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.
Other names
- GALAPAGOS · previous name